Latest 10-Q

What changed in Lycia Therapeutics, Inc.'s latest quarterly report, compared with the one before.

We have not read a recent 10-Q for this company yet.

IPO prospectus

Lycia Therapeutics, Inc.’s initial public offering: where it stands and what the registration statement says.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.Open-market buys and sales by officers, directors and 10% owners, from SEC Form 4. A plan set in advance is marked 10b5-1.

Loading…

13F holders

Funds that report this stock, checked against market prices.Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.Members of Congress, their spouses and dependent children report trades in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Lycia Therapeutics, Inc. and its lobbying firms report each quarter.A company that lobbies with its own staff reports its expenses; a lobbying firm it hires reports the income it received. We count both.

Loading…

H-1B labor applications at Lycia Therapeutics, Inc.

1 certified in 12 mo

Labor condition applications decided by the Department of Labor, matched to Lycia Therapeutics, Inc. by employer name. An application is not a hire.

Median yearly wage offered, full-time certified applications, Jul 2025 to Jun 2026: —The wage the employer offered, as filed, with its unit. The yearly figure restates it per year (hourly x 2,080, weekly x 52, every two weeks x 26, monthly x 12) from the low end of the offered range. It is not what the worker was paid.

H-1B labor applications decided at Lycia Therapeutics, Inc. by quarter
QuarterCertifiedAll decidedWorkers asked for
2024 Q3000
2024 Q4000
2025 Q1000
2025 Q2111
2025 Q3000
2025 Q4000
2026 Q1000
2026 Q2111
Most common job titles at Lycia Therapeutics, Inc.
Job titleApplicationsMedian wage
Senior Research Associate I1—

We match the employer's name to a public company automatically, including a reviewed list of subsidiaries. A subsidiary can be missed and a similar name can be matched wrongly. The files carry no worker names.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

About the company

The basics from the company’s SEC registration.

Loading…

$31.20−$1.63 (−4.96%) Nov 13 close
Oct 23, 2026: $30.00Oct 26, 2026: $28.85Oct 27, 2026: $26.11Oct 28, 2026: $25.05Oct 29, 2026: $27.73Oct 30, 2026: $26.40Nov 2, 2026: $27.18Nov 3, 2026: $27.60Nov 4, 2026: $28.92Nov 5, 2026: $28.80Nov 6, 2026: $30.50Nov 9, 2026: $30.36Nov 10, 2026: $31.30Nov 11, 2026: $31.44Nov 12, 2026: $32.83Nov 13, 2026: $31.20
Oct 23, 2026Low $25.05 · High $32.83Nov 13, 2026
Oct 23, 2026: $30.00Oct 26, 2026: $28.85Oct 27, 2026: $26.11Oct 28, 2026: $25.05Oct 29, 2026: $27.73Oct 30, 2026: $26.40Nov 2, 2026: $27.18Nov 3, 2026: $27.60Nov 4, 2026: $28.92Nov 5, 2026: $28.80Nov 6, 2026: $30.50Nov 9, 2026: $30.36Nov 10, 2026: $31.30Nov 11, 2026: $31.44Nov 12, 2026: $32.83Nov 13, 2026: $31.20
Oct 23, 2026Low $25.05 · High $32.83Nov 13, 2026
Oct 23, 2026: $30.00Oct 26, 2026: $28.85Oct 27, 2026: $26.11Oct 28, 2026: $25.05Oct 29, 2026: $27.73Oct 30, 2026: $26.40Nov 2, 2026: $27.18Nov 3, 2026: $27.60Nov 4, 2026: $28.92Nov 5, 2026: $28.80Nov 6, 2026: $30.50Nov 9, 2026: $30.36Nov 10, 2026: $31.30Nov 11, 2026: $31.44Nov 12, 2026: $32.83Nov 13, 2026: $31.20
Oct 23, 2026Low $25.05 · High $32.83Nov 13, 2026
Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.